Citation Impact
Citing Papers
Topographical and Temporal Diversity of the Human Skin Microbiome
2009 StandoutScience
Photodynamic therapy for non-melanoma skin cancer
2005
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial
2008
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up.
2008
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris
2010
The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis
2005
Psoriasis
2014
Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data
2009
Atopic Dermatitis
2008 Standout
Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
2008
The role of JAK/STAT signaling pathway and its inhibitors in diseases
2020
Psoriasis
2009 Standout
Research gaps in psoriasis: Opportunities for future studies
2013
Atopic dermatitis
2003 Standout
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
2005
Pathogenesis and clinical features of psoriasis
2007 Standout
Body dysmorphic disorder symptoms among patients with acne vulgaris
2007
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
The present and future role of photodynamic therapy in cancer treatment
2004 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Atopic dermatitis
2015 Standout
Photothermally enhanced photodynamic therapy based on mesoporous Pd@Ag@mSiO2 nanocarriers
2012
Scalp psoriasis: European consensus on grading and treatment algorithm
2009
Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus
2011
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
2007
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study
2011
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
Psoriasis
2021 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Comparison of Topical Methyl Aminolevulinate Photodynamic Therapy With Cryotherapy or Fluorouracil for Treatment of Squamous Cell Carcinoma In Situ
2006
Inflammatory Bowel Disease
2009 Standout
Advancements in the Treatment of Psoriasis: Role of Biologic Agents
2004
The pathogenic role of tissue-resident immune cells in psoriasis
2007
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
2001
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Psoriasis pathogenesis and the development of novel targeted immune therapies
2017
Psoriasis pathophysiology: current concepts of pathogenesis
2005
Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients
2009
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
2015
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
2004
Psoriasis
2015 Standout
Indocyanine green-based photodynamic therapy with 785 nm light emitting diode for oral squamous cancer cells
2011
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Psoriasis: emerging therapeutic strategies
2005
Photosensitizers in clinical PDT
2004
Milestones in the development of photodynamic therapy and fluorescence diagnosis
2007
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
2017
Dapsone 5% Gel
2009
Acne vulgaris
2011 Standout
The long-term efficacy and safety of new biological therapies for psoriasis
2006
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
2002
Oncologic photodynamic therapy photosensitizers: A clinical review
2010
Molluscum contagiosum virus infection
2013
Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g−1ointment and tacrolimus 0·3 mg g−1ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial
2007
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial
2005
Immunopathogenesis of Psoriasis
2007
Innate and adaptive immunity and the pathophysiology of psoriasis
2006
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
2020
Butenafine
1998
Photodynamic therapy of cancer: An update
2011 Standout
Ivermectin: panacea for resource-poor communities?
2014 StandoutNobel
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
2019
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
2017
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial
2016
Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany
2008
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy
2009
The physics, biophysics and technology of photodynamic therapy
2008
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
2006
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin
2004
Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice
2009
Methyl Aminolevulinate: Actinic Keratoses and Bowen's Disease
2007
Psoriasis
2005
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
2010
Systematic review of rosacea treatments
2006
Etanercept as Monotherapy in Patients with Psoriasis
2003
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis
2002
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
2006
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
2020
Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects
2016
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
2017
A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis
2004
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Fractionated Illumination at Low Fluence Rate Photodynamic Therapy in Mice
2010
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
2013
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
2004
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis
2003
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: An in vitro study
2006
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study
2012
Remote Assessment of Acne: The Use of Acne Grading Tools to Evaluate Digital Skin Images
2009
Oral Ivermectin for Treatment of Pediculosis Capitis
2010
X-ray excited ZnS:Cu,Co afterglow nanoparticles for photodynamic activation
2014
Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy
2009
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
2004
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison study
2012
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
1987 Standout
Covalently Assembled NIR Nanoplatform for Simultaneous Fluorescence Imaging and Photodynamic Therapy of Cancer Cells
2012
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Abrocitinib for the treatment of atopic dermatitis
2020
Management of psoriasis in adolescence
2014
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial
2018
Cutaneous T Cell Lymphoma
1986
Upconverting nanoparticles for pre‐clinical diffuse optical imaging, microscopy and sensing: Current trends and future challenges
2013
Copper Active Sites in Biology
2014 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Current states and future views in photodynamic therapy
2011
Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
2020
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
2014
Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials
2010
Butenafine and superficial mycoses: current status
2008
Current and Emerging Azole Antifungal Agents
1999 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Photodynamic Therapy Targets the mTOR Signaling Network in Vitro and in Vivo
2008
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials
2021
Sustainable Conversion of Carbon Dioxide: An Integrated Review of Catalysis and Life Cycle Assessment
2017 Standout
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
2015
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Selective JAK inhibitors in development for rheumatoid arthritis
2014
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
2007
TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors
2021
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
2015
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
The interpretation of long-term trials of biologic treatments for psoriasis: trial designs and the choices of statistical analyses affect ability to compare outcomes across trials
2013
Emerging Targets in Photopharmacology
2016 StandoutNobel
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
What have we learned in dermatology from the biologic therapies?
2006
Works of David M. Pariser being referenced
A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis
2000
Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
2008
Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis
2011
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
2006
Guidelines of care for superficial mycotic infections of the skin: Piedra
1996
Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open‐label, multicenter, Phase IIIb study
2007
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study
2004
OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
2014
Hematologic Safety of Dapsone Gel, 5%, for Topical Treatment of Acne Vulgaris
2008
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children
2001
A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
2003
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials
2018
Long-term etanercept in pediatric patients with plaque psoriasis
2010
Guidelines of care for superficial mycotic infections of the skin: Onychomycosis
1996
A Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel in the Topical Treatment of Papulopustular Rosacea
2003
Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis
1995
Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial
2006
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial
2003
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up
2006
Intermittent etanercept therapy in pediatric patients with psoriasis
2010
OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis
2013
Efficacy and safety of etanercept in children and adolescents aged≥8 years with severe plaque psoriasis
2010
Guidelines of care for superficial mycotic infections of the skin: Mucocutaneous candidiasis
1996
Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream
1997
A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis
2004
A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis
2013
Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study
2008
National Psoriasis Foundation Clinical Consensus on Disease Severity
2007
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
2008
Topical 0.5% Ivermectin Lotion for Treatment of Head Lice
2012
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis
2016
Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I
2005
Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005–09
2013
Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae
1996
Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
2007
Guidelines of care for superficial mycotic infectionsof the skin: Pityriasis (tinea) versicolor
1996
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
2004
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
2007
Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials
2004
Mycosis Fungoides Involving the Brain and Optic Nerves
1978
The oral Janus kinase/spleen tyrosine kinase inhibitorASN 002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
2019
Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
2016
Topical steroids: a guide for use in the elderly patient.
1991
AAD consensus statement on psoriasis therapies
2003
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
2003
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).
2015
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis
2015
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
2005
Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study
2017
Guidelines of care for superficial mycotic infectionsof the skin: Tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis
1996
Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study
2017